| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC1092 |
| Trial ID | CTRI/2023/03/050689 |
| Disease | Plasma Cell Neoplasm | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | DRL-1801 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | This study is a new type of treatment for B-Acute Lymphoblastic leukemia (a type of Blood Cancer) by using the patients own modified immune cells to target the cancer |
| Year | 2023 |
| Country | India |
| Company sponsor | Tata Memorial Hospital Research Administrative Council |
| Cohort 1 | |||||||||
|
|||||||||